COMP <GO>
GKOS vs SOLV // REVENUE GROWTH (YOY)
Glaukos Corporation (NYSE) VS. Solventum Corporation (NYSE) • 15-METRIC TALLY: GKOS 5
— SOLV 7
▲ REVENUE GROWTH (YOY) LEADER: GKOS
LAST: $237.60 (-2.01%) • MKT CAP: $14.35B
revenue-growth
32.30%
LAST: $81.33 (-2.67%) • MKT CAP: $14.22B
revenue-growth
0.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GKOS VS. SOLV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GKOS | SOLV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.70% | 53.50% | +2.20 | GKOS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.70% | 18.70% | -32.40 | SOLV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 7.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.16% | -0.07% | -0.09 | SOLV | /fcf-yield <GO> |
| Operating Margin | -39.30% | 26.20% | -65.50 | SOLV | /operating-margins <GO> |
| Net Profit Margin | -37.00% | 18.70% | -55.70 | SOLV | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 32.30% | 0.90% | +31.40 | GKOS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 2.25 | +23.75 | GKOS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | SOLV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 83.5 | 43.4 | +40.10 | GKOS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 1.06 | -0.02 | SOLV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 8.5x | +25.50 | SOLV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.35B | $14.22B | $130.2M | GKOS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GKOS REV | SOLV REV | GKOS GROSS % | SOLV GROSS % | GKOS FCF | SOLV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $507.4M | $8.32B | 55.7% | 53.5% | -$22.5M | -$10.0M |
| FY 2024 | $383.5M | $8.25B | 75.5% | 55.6% | -$67.6M | $805.0M |
| FY 2023 | $314.7M | $8.20B | — | — | -$71.9M | $1.55B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GKOS // BETA 1.04
SOLV // BETA 1.06